Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING-Melanoma

D Schadendorf, E Richtig, C Loquai, A Forschner, R Gutzmer, S Haferkamp, J Utikal, JC Hassel, F Meier, Dirk Debus, M Fluck, D Goeppner, H Kehrer, R Dummer, R von Moos, J Thompson, L Gengenbacher, O Michielin, C Hoeller

Research output: Contribution to journalpublished Abstract (Journal)peer-review

Original languageEnglish
Pages (from-to)236-236
JournalOncology Research and Treatment
Volume45
Issue numberSUPPL 3
Publication statusPublished - 2022

Cite this